1. Srinakharinwirot University Institutional Repository
  2. Articles from Academic Databases : SCOPUS
  3. Scopus 1983-2021
Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17413
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLaisuan W.
dc.contributor.authorWongsa C.
dc.contributor.authorChiewchalermsri C.
dc.contributor.authorThongngarm T.
dc.contributor.authorRerkpattanapipat T.
dc.contributor.authorIamrahong P.
dc.contributor.authorRuangwattanachok C.
dc.contributor.authorNanthapisal S.
dc.contributor.authorSompornrattanaphan M.
dc.date.accessioned2022-03-10T13:17:01Z-
dc.date.available2022-03-10T13:17:01Z-
dc.date.issued2021
dc.identifier.issn11786965
dc.identifier.other2-s2.0-85118542385
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17413-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85118542385&doi=10.2147%2fJAA.S333098&partnerID=40&md5=ea53204c87f5a790f324985731619e81
dc.description.abstractAnaphylaxis to CoronaVac, an inactivated vaccine against COVID-19, is extremely rare. We report 12 cases of anaphylaxis after CoronaVac administration, focusing on clinical characteristics and management outcomes. Skin test and graded vaccine challenge were successfully performed in our cases and might be considered if an inactivated vaccine is the only remaining option. © 2021 Laisuan et al. This work is published and licensed by Dove Medical Press Limited.
dc.languageen
dc.subjectcoronavac
dc.subjectimmunoglobulin G
dc.subjectinactivated vaccine
dc.subjectadult
dc.subjectanaphylaxis
dc.subjectArticle
dc.subjectBurkholderia pseudomallei
dc.subjectclinical article
dc.subjectcomplement activation
dc.subjectcoronavirus disease 2019
dc.subjectdrug hypersensitivity
dc.subjectfatigue
dc.subjectfemale
dc.subjectfever
dc.subjectgenetic variation
dc.subjectheadache
dc.subjecthuman
dc.subjectintensive care unit
dc.subjectmiddle aged
dc.subjectmortality
dc.subjectmyalgia
dc.subjectnose polyp
dc.subjectpetechia
dc.subjectprick test
dc.subjectrevaccination
dc.subjectshellfish allergy
dc.subjecttreatment outcome
dc.subjectvaccination
dc.titleCoronavac covid-19 vaccine-induced anaphylaxis: Clinical characteristics and revaccination outcomes
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Asthma and Allergy. Vol 14, No. (2021), p.1209-1215
dc.identifier.doi10.2147/JAA.S333098
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.